TIMP2 and neoplasm: We also investigated the effect of daily, systemic recombinant human TIMP2 (rTIMP2) delivery in tumor-bearing mice in a series of studies that highlight TIMP2 as a tumor-suppressor that functions within the tumor microenvironment of the diseased lung.